Guilhem Richard

Guilhem Richard is an accomplished biotechnology expert with extensive experience in technology and innovation. Currently serving as the Chief Technology Officer and Head of Innovation and Technology at EpiVax, Inc. since May 2024, Guilhem also provides consultancy services to GLG as an Expert Consultant. Previously, Guilhem held the position of Chief Scientific Officer/Chief Technology Officer at EpiVax Therapeutics, where responsibilities included overseeing technology improvements and market intelligence. Experience as Chief Technology Officer and Lead Computational Immunologist at EpiVax involved developing computational tools for vaccine designs. Earlier roles include independent software development and research at Boston University, culminating in a Ph.D. in Bioinformatics. Education includes a Master's degree from INSA Lyon.